Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and Parkinsonian Disorders

sb 203580 has been researched along with Parkinsonian Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alunni-Fabbroni, M; Baekelandt, V; Görner, K; Kahle, PJ; Pham, TT; Reumers, V; Schell, H; Vogt-Weisenhorn, D; Waak, J; Waldenmaier, A; Weber, SS; Wurst, W1
Clarkson, ED; Esplen, JE; Freed, CR; Heidenreich, KA; Marotti, J; Meintzer, MK; Rao, P; Wang, X; Zawada, WM1
Bales, KR; Bymaster, FP; Chernet, E; Dodel, RC; Du, Y; Gao, F; Lin, S; Luecke, S; Ma, Z; Nelson, DL; Paul, SM; Perry, KW; Phebus, LA; Triarhou, LC1

Other Studies

3 other study(ies) available for sb 203580 and Parkinsonian Disorders

ArticleYear
Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:8

    Topics: Animals; Apoptosis; Astrocytes; Base Sequence; Cells, Cultured; Cyclooxygenase 2; DNA, Complementary; Enzyme Inhibitors; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Lipopolysaccharides; Mice; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; Oncogene Proteins; p38 Mitogen-Activated Protein Kinases; Parkinsonian Disorders; Peroxiredoxins; Protein Deglycase DJ-1; Pyridines; Toll-Like Receptor 4

2009
Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons.
    Brain research, 2001, Feb-09, Volume: 891, Issue:1-2

    Topics: Animals; Brain Tissue Transplantation; Cell Survival; Cells, Cultured; Dopamine; Enzyme Inhibitors; Fetus; Graft Survival; Imidazoles; Male; Mitogen-Activated Protein Kinases; Neurons; p38 Mitogen-Activated Protein Kinases; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Recovery of Function

2001
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Dec-04, Volume: 98, Issue:25

    Topics: Animals; Caspase 1; Cells, Cultured; Dopamine; Humans; Imidazoles; Male; Mice; Mice, Inbred C57BL; Minocycline; Mitogen-Activated Protein Kinases; Monoamine Oxidase; MPTP Poisoning; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Parkinsonian Disorders; Phosphorylation; Pyridines; Visual Cortex

2001